These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 22617246)

  • 1. Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma.
    Kirschner MB; Cheng YY; Badrian B; Kao SC; Creaney J; Edelman JJ; Armstrong NJ; Vallely MP; Musk AW; Robinson BW; McCaughan BC; Klebe S; Mutsaers SE; van Zandwijk N; Reid G
    J Thorac Oncol; 2012 Jul; 7(7):1184-91. PubMed ID: 22617246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
    Bononi I; Comar M; Puozzo A; Stendardo M; Boschetto P; Orecchia S; Libener R; Guaschino R; Pietrobon S; Ferracin M; Negrini M; Martini F; Bovenzi M; Tognon M
    Oncotarget; 2016 Dec; 7(50):82700-82711. PubMed ID: 27716620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker.
    Spiekermann M; Belge G; Winter N; Ikogho R; Balks T; Bullerdiek J; Dieckmann KP
    Andrology; 2015 Jan; 3(1):78-84. PubMed ID: 25187505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs dysregulation in human malignant pleural mesothelioma.
    Balatti V; Maniero S; Ferracin M; Veronese A; Negrini M; Ferrocci G; Martini F; Tognon MG
    J Thorac Oncol; 2011 May; 6(5):844-51. PubMed ID: 21358347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
    Cavalleri T; Angelici L; Favero C; Dioni L; Mensi C; Bareggi C; Palleschi A; Rimessi A; Consonni D; Bordini L; Todaro A; Bollati V; Pesatori AC
    PLoS One; 2017; 12(5):e0176680. PubMed ID: 28472171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of circulating miR-548a-3p and -20a expression in malignant pleural mesothelioma patients.
    Matboli M; Shafei AE; Azazy AE; Reda M; El-Khazragy N; Nagy AA; Ali MA; Sobhi M; Abdel-Rahman O
    Biomark Med; 2018 Feb; 12(2):129-139. PubMed ID: 29338319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
    Lian F; Cui Y; Zhou C; Gao K; Wu L
    PLoS One; 2015; 10(3):e0121499. PubMed ID: 25775010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
    Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
    Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
    Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
    Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
    PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant Mesothelioma.
    Weber DG; Gawrych K; Casjens S; Brik A; Lehnert M; Taeger D; Pesch B; Kollmeier J; Bauer TT; Johnen G; Brüning T
    Dis Markers; 2017; 2017():9280170. PubMed ID: 28321148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
    Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X
    Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of microRNAs in gastrointestinal stromal tumors revealed by high throughput quantitative RT-PCR microarray.
    Tong HX; Zhou YH; Hou YY; Zhang Y; Huang Y; Xie B; Wang JY; Jiang Q; He JY; Shao YB; Han WM; Tan RY; Zhu J; Lu WQ
    World J Gastroenterol; 2015 May; 21(19):5843-55. PubMed ID: 26019448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
    Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma.
    Andersen M; Grauslund M; Ravn J; Sørensen JB; Andersen CB; Santoni-Rugiu E
    J Mol Diagn; 2014 Jul; 16(4):418-30. PubMed ID: 24912849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma microRNAs characterising patients with immune thrombocytopenic purpura.
    Zuo B; Zhai J; You L; Zhao Y; Yang J; Weng Z; Dai L; Wu Q; Ruan C; He Y
    Thromb Haemost; 2017 Jun; 117(7):1420-1431. PubMed ID: 28424819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer.
    Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S397-405. PubMed ID: 22956063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.
    Busacca S; Germano S; De Cecco L; Rinaldi M; Comoglio F; Favero F; Murer B; Mutti L; Pierotti M; Gaudino G
    Am J Respir Cell Mol Biol; 2010 Mar; 42(3):312-9. PubMed ID: 19502386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.